HOME >> MEDICINE >> NEWS
Jefferson neuroscientists studying new type of Alzheimer's drug to halt disease progression

Neuroscientists at the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia will begin a clinical trial testing a new type of drug that attacks amyloid, the protein substance that accumulates in the brains of Alzheimer's disease patients. The buildup of amyloid and the formation of tangles and plaques in the brain are thought to be major causes of the mind-robbing ravages of Alzheimer's disease.

Researchers led by Barry Rovner, M.D., director of Clinical Alzheimer's Disease Research at the Farber Institute for Neurosciences at Thomas Jefferson University and professor of psychiatry and neurology at Jefferson Medical College, and Samuel Gandy III, M.D., Ph.D., director of the Farber Institute for Neurosciences and professor of neurology and biochemistry and molecular pharmacology at Jefferson Medical College, are participating in a multicenter clinical trial to examine the effectiveness of a drug, Alzhemed, in halting the development of amyloid plaques and the progression of the disease in individuals with mild to moderate Alzheimer's.

Currently available medications such as Aricept, Reminyl, Exelon and Namenda treat only disease symptoms, explains Dr. Rovner.

Alzhemed is designed to act differently. "What's exciting about Alzhemed is that it works directly on the amyloid protein," says Dr. Rovner. Alzhemed is being investigated as a "disease-modifying" medication, he notes, with the objective to change the disease. "The hope is that it stabilizes the course of the disease, modifying its progression," Dr. Rovner says. "It's aimed at what is thought to be the central problem in the disease the buildup of protein in the brain that disrupts its message system."

The drug actually physically combines with amyloid to prevent plaque formation. It also is expected to inhibit the inflammatory response associated with amyloid buildup in Alzheimer's.

Drs. Rovner and Gandy will lead the Jefferson participa
'"/>


2-Nov-2004


Page: 1 2 3

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists help explain statins effects in Alzheimers disease
5. Jefferson scientists find zinc may help prevent esophageal, oral cancers
6. Jefferson virologists coax HIV out of hiding
7. Jefferson scientists find way to see breast cancer activity from outside the body
8. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
9. Jefferson scientists use gene therapy to rescue failing hearts in animals
10. Jefferson scientists reveal how some types of rabies invade the brain
11. Jefferson scientists uncover new evidence to help explain statins effects in Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... whose mission is to provide high-quality, intensive education and training that prepares graduates ... Joyce Williams as new member of the Board of Trustees. , Ms. Williams ...
(Date:6/28/2020)... ... June 27, 2020 , ... The FSHD Society announced ... conference in the organization’s history. The online conference takes the place of FSHD ... cancelled this year due to COVID-19. Nearly 300 individuals and families living with ...
(Date:6/24/2020)... ... June 24, 2020 , ... At Allerio we have chosen to ... and remote communications. We knew it had to be portable, it had to be ... just has to work. , We are proud to announce that Allerio has passed ...
(Date:6/24/2020)... ... 24, 2020 , ... Dr. Keith Chertok, esteemed periodontist serving ... tongue ties as well as sleep-disordered breathing. Recently completing a three-day training titled, ... teams including myofunctional therapists and sleep surgeons. , The Breathe Institute offers a ...
(Date:6/23/2020)... ... , ... In its latest report on companion diagnostics , IVD market ... tied to therapeutic selection or effectiveness. To get a sense of the current ... serving them to determine recent market trends. The analysts found:, ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... ... July 01, 2020 , ... ... International Business Awards® is Tuesday, July 28. , The International Business ... In 2019 the competition attracted more than 4,000 nominations from organizations in more ...
(Date:7/1/2020)... , ... July 01, 2020 , ... ... time ever, Stratodesk NoTouch OS is available on NComputing devices. Thanks to fantastic ... NComputing and Stratodesk have formed a new partnership that will make the full ...
(Date:6/28/2020)... ... 26, 2020 , ... Mediaplanet is proud to announce the ... providers, advocates, and scientists to spread awareness of chronic lung disease as well ... , More than 35 million Americans live with a chronic lung ...
Breaking Medicine Technology:
Cached News: